Which Biotech ETF Is the Better Buy: VanEck’s BBH or Invesco’s Factor-Driven PBE?

The VanEck Biotech ETF (NASDAQ: BBH) provides a low-cost, concentrated play on large-cap biotech leaders, whereas Invesco Biotechnology & Genome ETF (NYSEMKT: PBE) uses a multifactor approach that has recently offered higher yields and slightly better five-year total returns. Both funds seek to capture the growth of the healthcare and genetic research sectors but employ distinct methodologies.